Request Info


Ask for our annual reports or more information
Email Us

Email Alerts

Sign up for email alerts
Email Alerts
Investor Relations

SEC Filings

RSS RSS Feeds
Form 10-K
MERIDIAN BIOSCIENCE INC filed this Form 10-K on 11/29/2017
Document Outline
Entire Document (3757.6 KB)
Subdocument 1 - 10-K - ANNUAL REPORT
Page 1 - SECURITIES AND EXCHANGE COMMISSION
Page 2 - N/A
Page 3 - N/A
Page 4 - N/A
Page 5 - BUSINESS
Page 6 - www.meridianbioscience.com
Page 7 - N/A
Page 8 - illumi
Page 9 - Sales, Marketing and Distribution
Page 10 - Competition
Page 11 - Intellectual Property, Patents and Licenses
Page 12 - Medical Device Tax
Page 13 - Market Trends
Page 14 - Research and Development
Page 15 - Environmental
Page 16 - We may be unable to successfully integrate operations or to achieve expected cost savings from acqui
Page 17 - Changing Diagnostic Market Conditions
Page 18 - Efforts to reduce the U.S. federal deficit could adversely affect our results of operations.
Page 19 - Intense competition could adversely affect our profitability.
Page 20 - Risks Affecting our Manufacturing Operations
Page 21 - Significant interruptions in production at our principal manufacturing facilities and/or third-party
Page 22 - We depend on sole-source suppliers for certain critical raw materials, components and finished produ
Page 23 - Risks Related to Intellectual Property and Product Liability
Page 24 - Other Risks Affecting Our Business
Page 25 - Breaches of our information technology systems could have a material adverse effect on our operation
Page 26 - Natural disasters, war and other events could adversely affect our future revenues and operating inc
Page 27 - PROPERTIES
Page 28 - MINE SAFETY DISCLOSURES
Page 29 - SELECTED FINANCIAL DATA
Page 30 - illumi
Page 31 - N/A
Page 32 - USE OF NON-GAAP MEASURES
Page 33 - REVENUE OVERVIEW
Page 34 - Revenue Overview- By Product Platform/Type
Page 35 - Diagnostics Products
Page 36 - Immunoassay and Lead Testing Products
Page 37 - C. difficile
Page 38 - Medical Device Tax
Page 39 - Operating Expenses:
Page 40 - Diagnostics
Page 41 - Operating Income
Page 42 - N/A
Page 43 - Capital Resources
Page 44 - Known Contractual Obligations:
Page 45 - Market Risk Exposure:
Page 46 - Recent Accounting Pronouncements:
Page 47 - Classification of Certain Cash Receipts and Cash Payments
Page 48 - FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
Page 49 - REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
Page 50 - REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
Page 51 - Internal Control Integrated Framework
Page 52 - CONSOLIDATED STATEMENTS OF OPERATIONS (in thousands, except per share data)
Page 53 - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (dollars in thousands)
Page 54 - CONSOLIDATED BALANCE SHEETS (dollars in thousands)
Page 55 - CONSOLIDATED BALANCE SHEETS (dollars in thousands)
Page 56 - CONSOLIDATED STATEMENTS OF SHAREHOLDERS EQUITY (dollars and shares in thousands, except per share da
Page 57 - CONSOLIDATED STATEMENTS OF CASH FLOWS (dollars in thousands)
Page 58 - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Page 59 - N/A
Page 60 - N/A
Page 61 - N/A
Page 62 - illumi
Page 63 - illumi
Page 64 - N/A
Page 65 - Leases
Page 66 - Intra-Entity Transfers of Assets Other Than Inventory
Page 67 - N/A
Page 68 - N/A
Page 69 - N/A
Page 70 - N/A
Page 71 - N/A
Page 72 - N/A
Page 73 - N/A
Page 74 - N/A
Page 75 - N/A
Page 76 - N/A
Page 77 - illumi
Page 78 - N/A
Page 79 - N/A
Page 80 - N/A
Page 81 - N/A
Page 82 - CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS
Page 83 - Management s Report on Internal Control over Financial Reporting
Page 84 - Changes in Internal Control over Financial Reporting
Page 85 - EQUITY COMPENSATION PLAN INFORMATION
Page 86 - N/A
Page 87 - N/A
Page 88 - FORM 10-K SUMMARY
Page 89 - N/A
Page 90 - Year Ended September 30, 2017:
Subdocument 2 - EX-10.9 - EX-10.9
Page 1 - Exhibit 10.9
Page 2 - provided however,
Page 3 - NON GAAP MEASUREMENT
Subdocument 3 - EX-10.10 - EX-10.10
Page 1 - EXHIBIT 10.10
Page 2 - 3. Forfeiture of Restricted Units.
Page 3 - N/A
Page 4 - 20. Governing Law.
Page 5 - N/A
Subdocument 4 - EX-10.11 - EX-10.11
Page 1 - EXHIBIT 10.11
Page 2 - N/A
Page 3 - seventh
Page 4 - N/A
Page 5 - forum non conveniens
Subdocument 5 - EX-10.12 - EX-10.12
Page 1 - EXHIBIT 10.12
Page 2 - 4. Exercise and Payment.
Page 3 - Tax Date
Page 4 - forum non conveniens
Subdocument 6 - EX-10.13 - EX-10.13
Page 1 - EXHIBIT 10.13
Page 2 - 4. Exercise and Payment.
Page 3 - N/A
Page 4 - 18. Governing Law.
Page 5 - N/A
Subdocument 7 - EX-10.16.8 - EX-10.16.8
Page 1 - EXHIBIT 10.16.8
Page 2 - General.
Page 3 - N/A
Subdocument 8 - EX-10.16.9 - EX-10.16.9
Page 1 - EXHIBIT 10.16.9
Page 2 - General.
Page 3 - N/A
Subdocument 9 - EX-13 - EX-13
Page 1 - Exhibit 13
Page 2 - Corporate Data
Page 3 - N/A
Page 4 - PERFORMANCE GRAPH
Subdocument 10 - EX-21 - EX-21
Page 1 - Exhibit 21
Subdocument 11 - EX-23 - EX-23
Page 1 - Exhibit 23
Subdocument 12 - EX-31.1 - EX-31.1
Page 1 - Exhibit 31.1
Subdocument 13 - EX-31.2 - EX-31.2
Page 1 - Exhibit 31.2
Subdocument 14 - EX-32 - EX-32
Page 1 - Exhibit 32
XBRL Item - EX-101.INS - XBRL INSTANCE DOCUMENT (What's this?)
XBRL Item - EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA (What's this?)
XBRL Item - EX-101.CAL - XBRL TAXONOMY EXTENSION CALCULATION LINKBASE (What's this?)
XBRL Item - EX-101.DEF - XBRL TAXONOMY EXTENSION DEFINITION LINKBASE (What's this?)
XBRL Item - EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE (What's this?)
XBRL Item - EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE (What's this?)
XBRL Viewer